KFS
AGN

Kelly Financial Services’s Allergan plc AGN Stock Holding History

Kelly Financial Services’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26
Closed -$4.61K – 622
2020
Q1 		$4.61K Hold
26
– – 0.01% 305
2019
Q4 		$4.97K Sell
26
-61
-70% -$11K ﹤0.01% 302
2019
Q3 		$14.6K Buy
87
+1
+1% +$163 0.01% 184
2019
Q2 		$14.5K Hold
86
– – 0.01% 187
2019
Q1 		$12.6K Buy
+86
New +$12.5K 0.01% 195

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Kelly Financial Services's AGN Position: Q2 2020 in Review

Kelly Financial Services sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 26 shares — an estimated $4.61K sold.

Kelly Financial Services first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $14.6K in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Kelly Financial Services reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Kelly Financial Services sold 26 Allergan plc shares in Q2 2020, an estimated $4.61K.
  • Kelly Financial Services first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Kelly Financial Services's Allergan plc position peaked at $14.6K in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Kelly Financial Services's 13F filing for Q2 2020, filed 17 Jul 2024.